Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence

Journal of Substance Abuse Treatment

Volumn 57, Issue , 2015, Pages 70-74

  McRae Clark, Aimee L ^a   Baker, Nathaniel L ^a   Sonne, Susan C ^a   DeVane, C Lindsay ^a   Wagner, Amanda ^a   Norton, Jessica ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adherence; Biological marker; Drug level monitoring; Medication diary; Self report

Indexed keywords

6 HYDROXYBUSPIRONE; BUSPIRONE; CANNABIS; PLACEBO; RIBOFLAVIN; SEROTONIN AGONIST; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD CHEMISTRY; CANNABIS ADDICTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG URINE LEVEL; FEMALE; HUMAN; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PILL; PRIORITY JOURNAL; SELF REPORT; SERUM; TREATMENT DURATION; URINALYSIS; YOUNG ADULT; BLOOD; MARIJUANA ABUSE; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; URINE;

ADULT; BIOMARKERS; BUSPIRONE; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MEDICATION ADHERENCE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RIBOFLAVIN; SELF REPORT; SEROTONIN RECEPTOR AGONISTS; YOUNG ADULT;

EID: 84940575122     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2015.05.002     Document Type: Article

References (15)

1. Anderson A.L., Li S.-H., Biswas K., McSherry F., Holmes T., Iturriaga E., et al. Modafinil for the treatment of methamphetamine dependence. Drug and Alcohol Dependence 2012, 120:135-141.
2. Babiker I.E., Cooke P.R., Gillett M.G. How useful is riboflavin as a tracer of medication compliance?. Journal of Behavioral Medicine 1989, 12:25-38.
3. Baros A.M., Latham P.K., Moak D.H., Voronin K., Anton R.F. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?. Alcoholism, Clinical and Experimental Research 2007, 31:596-603.
4. Byrt T., Bishop J., Carlin J.B. Bias, prevalence and kappa. Journal of Clinical Epidemiology 1993, 46:423-429.
5. Dockens R.C., Salazar D.E., Fulmor I.E., Wehling M., Arnold M.E., Croop R. Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range. Journal of Clinical Pharmacology 2006, 46:1308-1312.
6. Dockens R.C., Tran A.Q., Zeng J., Croop R. Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans. Biopharmaceutics & Drug Disposition 2007, 28:393-402.
7. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics 1999, 21:1074-1090.
8. Feinn R., Tennen H., Cramer J., Kranzler H.R. Measurement and prediction of medication compliance in problem drinkers. Alcoholism, Clinical and Experimental Research 2003, 27:1286-1292.
9. Herron A.J., Mariani J.J., Pavlicova M., Parrinello C.M., Bold K.W., Levin F.R., et al. Assessment of riboflavin as a tracer substance: Comparison of a qualitative to a quantitative method of riboflavin measurement. Drug and Alcohol Dependence 2013, 128:77-82.
10. Mooney M., Sayre S., Green C., Rhoades H., Schmitz J. Comparing measures of medication taking in a pharmacotherapy trial for cocaine dependence. Addictive Disorders and Their Treatment 2004, 3:165-173.
11. Pan W. Akaike's information criterion in generalized estimating equations. Biometrics 2001, 57:120-125.
12. Sowers W., Golden S. Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. Journal of Psychoactive Drugs 1999, 31:59-70.
13. Spilker B. Methods of assessing and improving patient compliance in clinical trials. Patient compliance in medical practice and clinical trials 1991, 37-56. Raven Press, New York. J.A. Cramer, B. Spilker (Eds.).
14. Williams A.B., Amico K.R., Bova C., Womack J.A. A proposal for quality standards for measuring adherence in research. AIDS and Behavior 2013, 17:284-297.
15. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42:121-130.